Literature DB >> 33124539

Antibody Profiles to P. falciparum Antigens Over Time Characterize Acute and Long-Term Malaria Exposure in an Area of Low and Unstable Transmission.

Bartholomew N Ondigo1,2,3, Karen E S Hamre4,5,6, Anne E P Frosch7,8, George Ayodo2,9, Michael T White10, Chandy C John2,4,11.   

Abstract

Prevalence and levels of antibodies to multiple Plasmodium falciparum antigens show promise as tools for estimating malaria exposure. In a highland area of Kenya with unstable transmission, we assessed the presence and levels of antibodies to 12 pre-erythrocytic and blood-stage P. falciparum antigens by multiplex cytometric bead assay or ELISA in 604 individuals in August 2007, with follow-up testing in this cohort in April 2008, April 2009, and May 2010. Four hundred individuals were tested at all four time points. During this period, the only substantial malaria incidence occurred from April to August 2009. Antibody prevalence in adults was high at all time points (> 70%) for apical membrane antigen 1, erythrocyte-binding antigen 175, erythrocyte-binding protein-2, glutamate rich protein (GLURP)-R2, merozoite surface protein (MSP) 1 (19), MSP-1 (42), and liver-stage antigen-1; moderate (30-70%) for GLURP-R0, MSP-3, and thrombospondin-related adhesive protein; and low (< 30%) for SE and circumsporozoite protein (CSP). Changes in community-wide malaria exposure were best reflected in decreasing antibody levels overtime for highly immunogenic antigens, and in antibody seroprevalence overtime for the less-immunogenic antigens. Over the 3 years, antibody levels to all antigens except CSP and schizont extract (SE) decreased in an age-dependent manner. Prevalence and levels of antibodies to all antigens except CSP and SE increased with age. Increases in antibody prevalence and levels to CSP and SE coincided with increases in community-wide malaria incidence. Antibody levels to multiple P. falciparum antigens decrease in the absence of consistent transmission. Multiplex assays that assess both the presence and level of antibodies to multiple pre-erythrocytic and blood-stage P. falciparum antigens may provide the most useful estimates of past and recent malaria transmission in areas of unstable transmission and could be useful tools in malaria control and elimination campaigns.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33124539      PMCID: PMC7695089          DOI: 10.4269/ajtmh.19-0480

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  35 in total

1.  A stochastic model of schistosomiasis immuno-epidemiology.

Authors:  M S Chan; V S Isham
Journal:  Math Biosci       Date:  1998-08-01       Impact factor: 2.144

2.  Dynamics of the antibody response to Plasmodium falciparum infection in African children.

Authors:  Michael T White; Jamie T Griffin; Onome Akpogheneta; David J Conway; Kwadwo A Koram; Eleanor M Riley; Azra C Ghani
Journal:  J Infect Dis       Date:  2014-04-08       Impact factor: 5.226

3.  Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens.

Authors:  Bartholomew N Ondigo; Gregory S Park; Severin O Gose; Benjamin M Ho; Lyticia A Ochola; George O Ayodo; Ayub V Ofulla; Chandy C John
Journal:  Malar J       Date:  2012-12-21       Impact factor: 2.979

4.  Estimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models.

Authors:  Emilie Pothin; Neil M Ferguson; Chris J Drakeley; Azra C Ghani
Journal:  Malar J       Date:  2016-02-09       Impact factor: 2.979

5.  Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya.

Authors:  Grace E Weber; Michael T White; Anna Babakhanyan; Peter Odada Sumba; John Vulule; Dylan Ely; Chandy John; Evelina Angov; David Lanar; Sheetij Dutta; David L Narum; Toshihiro Horii; Alan Cowman; James Beeson; Joseph Smith; James W Kazura; Arlene E Dent
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

6.  Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure.

Authors:  Victor Yman; Michael T White; Muhammad Asghar; Christopher Sundling; Klara Sondén; Simon J Draper; Faith H A Osier; Anna Färnert
Journal:  BMC Med       Date:  2019-01-30       Impact factor: 8.775

7.  Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection.

Authors:  Shona Wilson; Mark Booth; Frances M Jones; Joseph K Mwatha; Gachuhi Kimani; H Curtis Kariuki; Birgitte J Vennervald; John H Ouma; Eric Muchiri; David W Dunne
Journal:  BMC Infect Dis       Date:  2007-06-29       Impact factor: 3.090

Review 8.  Antibody Correlates of Protection from Clinical Plasmodium falciparum Malaria in an Area of Low and Unstable Malaria Transmission.

Authors:  Karen E S Hamre; Bartholomew N Ondigo; James S Hodges; Sheetij Dutta; Michael Theisen; George Ayodo; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2020-10-27       Impact factor: 3.707

9.  Use of different transmission metrics to describe malaria epidemiology in the highlands of western Kenya.

Authors:  Jennifer C Stevenson; Gillian H Stresman; Amrish Baidjoe; Albert Okoth; Robin Oriango; Chrispin Owaga; Elizabeth Marube; Teun Bousema; Jonathan Cox; Chris Drakeley
Journal:  Malar J       Date:  2015-10-26       Impact factor: 2.979

Review 10.  Taking Sharper Pictures of Malaria with CAMERAs: Combined Antibodies to Measure Exposure Recency Assays.

Authors:  Bryan Greenhouse; David L Smith; Isabel Rodríguez-Barraquer; Ivo Mueller; Chris J Drakeley
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

View more
  5 in total

1.  Spatial Distribution of Plasmodium falciparum and Plasmodium vivax in Northern Ethiopia by Microscopic, Rapid Diagnostic Test, Laboratory Antibody, and Antigen Data.

Authors:  Colleen M Leonard; Ashenafi Assefa; Heven Sime; Hussein Mohammed; Amha Kebede; Hiwot Solomon; Chris Drakeley; Matt Murphy; Jimee Hwang; Eric Rogier
Journal:  J Infect Dis       Date:  2022-03-02       Impact factor: 5.226

Review 2.  Targeting the Plasmodium falciparum proteome and organelles for potential antimalarial drug candidates.

Authors:  James Abugri; Joseph Ayariga; Samuel Sunyazi Sunwiale; Cletus Adiyaga Wezena; Julien Agyemang Gyamfi; Michael Adu-Frimpong; Godfred Agongo; Julius Tieroyaare Dongdem; Daniel Abugri; Bismarck Dinko
Journal:  Heliyon       Date:  2022-08-24

3.  Plasmodium falciparum serology: A comparison of two protein production methods for analysis of antibody responses by protein microarray.

Authors:  Tate Oulton; Joshua Obiero; Isabel Rodriguez; Isaac Ssewanyana; Rebecca A Dabbs; Christine M Bachman; Bryan Greenhouse; Chris Drakeley; Phil L Felgner; Will Stone; Kevin K A Tetteh
Journal:  PLoS One       Date:  2022-08-29       Impact factor: 3.752

4.  Community-based molecular and serological surveillance of subclinical malaria in Myanmar.

Authors:  Katherine O'Flaherty; Win Han Oo; Sophie G Zaloumis; Julia C Cutts; Kyaw Zayar Aung; Myat Mon Thein; Damien R Drew; Zahra Razook; Alyssa E Barry; Naanki Parischa; Nyi Nyi Zaw; Htin Kyaw Thu; Aung Thi; Wai Yan Min Htay; Aung Paing Soe; Julie A Simpson; James G Beeson; Paul A Agius; Freya J I Fowkes
Journal:  BMC Med       Date:  2021-05-28       Impact factor: 8.775

5.  Opportunities for Subnational Malaria Elimination in High-Burden Countries.

Authors:  Kim A Lindblade; S Patrick Kachur
Journal:  Am J Trop Med Hyg       Date:  2020-10-27       Impact factor: 3.707

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.